Invention Publication
- Patent Title: VITAMIN C RENAL LEAK AS A CLINICAL DIAGNOSTIC TOOL IN THE DETECTION, MONITORING, AND MANAGEMENT OF ACUTE AND CHRONIC DISEASES
-
Application No.: US18563663Application Date: 2022-05-25
-
Publication No.: US20240248101A1Publication Date: 2024-07-25
- Inventor: Mark A. Levine , Ifechukwude C. Ebenuwa , Pierre-Christian Violet
- Applicant: Mark A. Levine , Ifechukwude C. Ebenuwa , Pierre-Christian Violet
- Applicant Address: US DC Washington
- Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Servic
- Current Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Servic
- Current Assignee Address: US MD Bethesda
- International Application: PCT/US2022/030935 2022.05.25
- Date entered country: 2023-11-22
- Main IPC: G01N33/82
- IPC: G01N33/82 ; A61K31/375 ; A61K45/06 ; A61P13/12 ; G01N30/02 ; G01N30/64 ; G01N30/88

Abstract:
The invention provides a method involving assessing the vitamin C renal leak status of a human subject, vitamin C renal leak being the clinically inappropriate presence of vitamin C in urine. The method comprises assaying for the concentration of vitamin C in a plasma sample and in collected urine output, whereby the presence of vitamin C in the collected urine output and a concentration of vitamin C in the plasma sample less than the Minimum Elimination Threshold (MET) indicates the presence of vitamin C renal leak. Vitamin C renal leak also can be quantified by determining the fractional excretion of vitamin C (FeVC), which is a measurement of the degree of urinary vitamin C excretion relative to plasma vitamin C concentration corrected by creatinine clearance. The invention also provides a test kit for assessing vitamin C renal leak and a test kit for assessing FeVC.
Information query
IPC分类: